Concentrix Corporation
NASDAQ:CNXCInformation Technology Services
-$0.75 today
- Market cap
- $1.85B
- Beta
- 0.42
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$21.66
- Dividend yield
- 5.73%
Volume 0.65M
Average 1.64M
CNXC Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Concentrix CorporationNASDAQ: CNXC
Accounts Payables · Q1 FY2026 · quarter ended Feb 2026
Accounts payables grows, but more slowly than its trailing trend
Q1 FY2026 accounts payables of $44.6M (cash outflow) rose 18.8% year over year, behind the +179.8% change in trailing-twelve-month accounts payables. Over 3 fiscal years it compounded at +24.9% a year.
Context
- Accounts payables amounted to 0.3% of revenue in FY2025, unchanged from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +18.8% toward the trailing-twelve-month pace of +179.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 28.47M USD
- Year-over-year change
- +210.3%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 28.47M | +210.3% |
| FY2024 | 2024-11-30 | (25.82M) | -376.4% |
| FY2023 | 2023-11-30 | 9.34M | -36.1% |
| FY2022 | 2022-11-30 | 14.63M | +421.7% |
| FY2021 | 2021-11-30 | (4.55M) | — |
Accounts Payables vs competitors
How CNXC compares with its peers on the latest reported figures
- CNXC's LTM Feb 2026 accounts payables of $21.41M is the 3rd largest of the 9 companies compared; the peer median is $7.06M.
- Its year-over-year change of +179.8% is the 2nd highest of 9, against a peer median of +15.2%.
- Accounts payables amounts to 0.2% of revenue for CNXC, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $24.36M | -18.1% | +62.9% | 0.4% | |
| LTM Jun 2026 | $21.41M | +19913.1% | +209.0% | 6.8% | |
| LTM Feb 2026 | $21.41M | +179.8% | +24.9% | 0.2% | |
| LTM Mar 2026 | $17.26M | +62.1% | — | 0.8% | |
| LTM Jun 2026 | $10.63M | -64.2% | +67.6% | 0.5% | |
| LTM Mar 2026 | $9.29M | +99.2% | +39.4% | 1.5% | |
| LTM Mar 2026 | $8.7M | -152.7% | — | 0.4% | |
| LTM Apr 2026 | $4.83M | -33.0% | -25.8% | 0.6% | |
| LTM Mar 2026 | $315K | +48.6% | — | 0.1% | |
| Peer median (excluding CNXC) | $7.06M | +15.2% | +62.9% | 0.5% | |
Competitors are the stored peer set for CNXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Net Income | 405.58M | 435.64M | 313.84M | 251.22M | (1.28B) |
| Depreciation & Amortization | 277.18M | 309.54M | 388.3M | 705.85M | 660.43M |
| Deferred Income Tax | (25.73M) | (30.82M) | (121.71M) | (235.25M) | (154.88M) |
| Stock-Based Compensation | 36.18M | 47.14M | 62.11M | 96.06M | 96.39M |
| Change in Working Capital | (165.46M) | (165.02M) | (10.66M) | (166.89M) | (85.76M) |
| Accounts Receivables | (139.1M) | (53.13M) | (45.9M) | (63.85M) | (23.08M) |
| Inventory | (22.83M) | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.55M) | 14.63M | 9.34M | (25.82M) | 28.47M |
| Other Working Capital | 1.02M | (126.51M) | 25.9M | (77.22M) | (91.16M) |
| Other Non-Cash Items | (13.56M) | 4.24M | 46.13M | 16.51M | 1.57B |
| Operating Cash Flow | 514.18M | 600.72M | 678.01M | 667.49M | 806.97M |
| Capital Expenditures | (149.08M) | (140.02M) | (180.53M) | (238.76M) | (234.5M) |
| Acquisitions (Net) | 70.43M | (1.7B) | (1.91B) | (5.5M) | (15.89M) |
| Purchases of Investments | 0 | (1M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 1M | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1M) | (14.63M) | 0 | 0 |
| Investing Cash Flow | (78.65M) | (1.84B) | (2.11B) | (244.27M) | (250.38M) |
| Debt Repayment | (345M) | 1.43B | 1.98B | (208.69M) | (196.69M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 3.98M |
| Common Stock Repurchased | (57.49M) | (133.29M) | (81.19M) | (149.48M) | (188.71M) |
| Dividends Paid | (13.08M) | (53.43M) | (63.5M) | (83.81M) | (89.62M) |
| Other Financing Activities | 13.7M | (2.24M) | (36.63M) | (50.56M) | (20.4M) |
| Financing Cash Flow | (401.87M) | 1.24B | 1.8B | (492.53M) | (491.44M) |
| Effect of Forex Changes | (7M) | (24.52M) | (12.42M) | (17.58M) | 26.38M |
| Net Change in Cash | 26.66M | (25.55M) | 359.02M | (86.88M) | 91.52M |
| Free Cash Flow | 365.1M | 460.7M | 497.48M | 428.73M | 572.47M |
Concentrix Corporation
NASDAQ:CNXC
Intrinsic Alpha fair value
Locked
Current Price
$30.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.